
Eli Lilly and Insilico Medicine Expand AI Drug Discovery Partnership with Multibillion-Dollar Deal
Global pharmaceutical company Eli Lilly has expanded its partnership with Insilico Medicine, signing a potential multibillion-dollar deal to license an early-stage drug pipeline and utilize Insilico's artificial intelligence platform for drug development.

